| Self-assembly enhances the strength of fibers made from vimentin intermediate filament proteins N Pinto, FC Yang, A Negishi, MC Rheinstädter, TE Gillis, DS Fudge Biomacromolecules 15 (2), 574-581, 2014 | 45 | 2014 |
| ERK-TSC2 signalling in constitutively-active HRAS mutant HNSCC cells promotes resistance to PI3K inhibition KM Ruicci, N Pinto, MI Khan, J Yoo, K Fung, D MacNeil, JS Mymryk, ... Oral oncology 84, 95-103, 2018 | 41 | 2018 |
| Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer F Ghasemi, M Black, F Vizeacoumar, N Pinto, KM Ruicci, CCSH Le, ... Oncotarget 8 (42), 71512, 2017 | 38 | 2017 |
| Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition KM Ruicci, P Plantinga, N Pinto, MI Khan, W Stecho, SS Dhaliwal, J Yoo, ... Molecular oncology 13 (10), 2160-2177, 2019 | 32 | 2019 |
| Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status F Ghasemi, SD Prokopec, D MacNeil, N Mundi, SF Gameiro, C Howlett, ... JCI insight 4 (1), 2019 | 30 | 2019 |
| A controlled trial of HNSCC patient‐derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growth KM Ruicci, J Meens, RX Sun, G Rizzo, N Pinto, J Yoo, K Fung, D MacNeil, ... International Journal of Cancer 145 (8), 2100-2106, 2019 | 29 | 2019 |
| Exploiting high-throughput cell line drug screening studies to identify candidate therapeutic agents in head and neck cancer AC Nichols, M Black, J Yoo, N Pinto, A Fernandes, B Haibe-Kains, ... BMC Pharmacology and Toxicology 15, 1-10, 2014 | 28 | 2014 |
| Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer N Pinto, M Black, K Patel, J Yoo, JS Mymryk, JW Barrett, AC Nichols Journal of oncology 2014 (1), 936285, 2014 | 25 | 2014 |
| Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models N Pinto, SD Prokopec, F Vizeacoumar, K Searle, M Lowerison, KM Ruicci, ... PLoS One 13 (11), e0207152, 2018 | 21 | 2018 |
| Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer models N Pinto, SD Prokopec, F Ghasemi, J Meens, KM Ruicci, IM Khan, N Mundi, ... PLoS One 15 (9), e0239315, 2020 | 19 | 2020 |
| Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival N Mundi, SD Prokopec, F Ghasemi, A Warner, K Patel, D MacNeil, ... Cancers of the head & neck 4, 1-8, 2019 | 17 | 2019 |
| The genomic and evolutionary landscapes of anaplastic thyroid carcinoma PYF Zeng, SD Prokopec, SY Lai, N Pinto, MA Chan-Seng-Yue, ... Cell reports 43 (3), 2024 | 15 | 2024 |
| TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma KM Ruicci, J Meens, P Plantinga, W Stecho, N Pinto, J Yoo, K Fung, ... Journal of Experimental & Clinical Cancer Research 39, 1-18, 2020 | 15 | 2020 |
| High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell lines F Ghasemi, M Black, RX Sun, F Vizeacoumar, N Pinto, KM Ruicci, J Yoo, ... Oncotarget 9 (40), 26064, 2018 | 15 | 2018 |
| The control of anaplastic thyroid carcinoma cell lines by oncolytic poxviruses N Mundi, S Um, J Yoo, G Rizzo, M Black, N Pinto, DA Palma, K Fung, ... Virus research 190, 53-59, 2014 | 14 | 2014 |
| Introduction and expression of PIK3CAE545K in a papillary thyroid cancer BRAFV600E cell line leads to a dedifferentiated aggressive phenotype N Pinto, KM Ruicci, MI Khan, MH Shaikh, YFP Zeng, J Yoo, K Fung, ... Journal of Otolaryngology-Head & Neck Surgery 51 (1), 7, 2022 | 13 | 2022 |
| Spleen tyrosine kinase expression is correlated with human papillomavirus in head and neck cancer M Black, F Ghasemi, RX Sun, W Stecho, A Datti, J Meens, N Pinto, ... Oral Oncology 101, 104529, 2020 | 10 | 2020 |
| Detection of circulating tumor DNA in patients with thyroid nodules KB Patel, N Cormier, J Fowler, A Partridge, J Theurer, M Black, N Pinto, ... International Journal of Endocrinology 2021 (1), 8909224, 2021 | 9 | 2021 |
| Feasibility of Targeting PIK3CA Mutations in Head and Neck Squamous Cell Carcinoma JA Theurer, W Stecho, J Yoo, K Kwan, B Wehrli, V Harry, M Black, N Pinto, ... Pathology & Oncology Research 22, 35-40, 2016 | 6 | 2016 |
| Erratum to: Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition KM Ruicci, P Plantinga, N Pinto, MI Khan, W Stecho, SS Dhaliwal, J Yoo, ... Molecular Oncology 14 (1), 230, 2019 | 2 | 2019 |